2DeFronzo RA. Pathogenesis of type 2 diabetes mellitus[J]. Med Clin North Am,2004,88: 787-835.
3Tamura S, Shimomura I. Contribution of adipose tissue and de novo lipogenesis to nonalcoholic fatty liver disease[J]. J Clin Invest,2005,115 : 1139-1142.
4Kawaguchi T, Takenoshita M, Kabashima T, et al. Glucose and cAMP regulate the L-type pyruvate kinase gene by phosphorylation/ dephosphorylation of the carbohydrate response element binding protein[J]. Proc Natl Acad Sei U S A,2001, 98:13710-13715.
5Zhou G, Myers R, Li Y, et al. Role of AMP-activated protein kinase in mechanism of metformin action[J]. J Clin Invest, 2001,108: 1167-1174.
6Fong DG, Nehra V, Lindor KD,et al. Metabolic and nutritional considerations in nonalcoholic fatty liver[J]. Hepatology, 2000, 32: 3-10.
7Charlton M, Sreekumar R, Rasmussen D, et al. Apolipoprotein synthesis in nonalcoholic steatohepatitis [J ]. Hepatology, 2002, 35: 898-904.
8Mannaerts GP, Van Veldhoven PP, Casteels M. Peroxisomal lipid degradation via beta- and alpha-oxidation in mammals[J]. Cell Bioehem Biophys,2000, 32 Spring: 73-87.
9Lieber CS. CYP2E1: from ASH to NASH[J]. Hepatol Res, 2004, 28: 1-11.
10Brownlee M. The pathobiology of diabetic complications: a unifying mechanism[J]. Diabetes,2005, 54: 1615-1625.
二级参考文献50
1Younossi ZM,Diehl AM, Ong JP. Hepatology, 2002;35:746-752
2Xu A,Wang Y,Keshaw H, et al. Eur J Endocrinol. ,2003;148:293-300
3Statnick MA, Beavers LS, Conner LJ, et al. Int J Exp Diabetes Res,2000 ; 1:81 -88
4Beltowski J. Med Sci Monit,2003 ;9:RA55-61
5Takahashi M, Arita Y, Yamagata K, et al. Int J Obes Relat Metab Disord,2000 ;24: 861 - 868
